Henshaw Capital’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $737K | Sell |
|
|||||
|
2025
Q2 | $664K | Hold |
|
|||||
|
2025
Q1 | $690K | Buy |
|
|||||
|
2024
Q4 | $710K | Buy |
|
|||||
|
2024
Q3 | $558K | Hold |
|
|||||
|
2024
Q2 | $479K | Buy |
|
|||||
|
2024
Q1 | $595K | Hold |
|
|||||
|
2023
Q4 | $505K | Hold |
|
|||||
|
2023
Q3 | $481K | Buy |
|
|||||
|
2023
Q2 | $306K | Hold |
|
|||||
|
2023
Q1 | $369K | Hold |
|
|||||
|
2022
Q4 | $363K | Hold |
|
|||||
|
2022
Q3 | $345K | Buy |
|
|||||
|
2022
Q2 | $258K | Hold |
|
|||||
|
2022
Q1 | $288K | Hold |
|
|||||
|
2021
Q4 | $260K | Hold |
|
|||||
|
2021
Q3 | $238K | Hold |
|
|||||
|
2021
Q2 | $275K | Hold |
|
|||||
|
2021
Q1 | $234K | Hold |
|
|||||
|
2020
Q4 | $224K | Buy |
|